Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells

  • Authors:
    • Dominika Nowis
    • Magdalena Legat
    • Jacek Bil
    • Zuzanna Kurzaj
    • Tadeusz Issat
    • Tomasz Stoklosa
    • Barbara Mioduszewska
    • Leszek Kaczmarek
    • Marek Jakóbisiak
    • Jakub Golab
  • View Affiliations

  • Published online on: December 1, 2007     https://doi.org/10.3892/ijo.31.6.1547
  • Pages: 1547-1552
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cisplatin, a widely used chemotherapeutic is approved for the management of various solid tumors. Administration of cisplatin is associated with induction of significant toxicities that include neurotoxicity and nephrotoxicity, the latter leading to severe and debilitating anemia. Since erythropoietin, a hematopoietic growth factor that corrects chemotherapy-induced anemia, reduces transfusion requirements and seems to improve the patient's quality of life, has been shown to exert cytoprotective effects we decided to investigate its direct influence on cisplatin-induced neurotoxicity against primary cortical neurons isolated from rats. We observed that pre-treatment of neurons with erythropoietin significantly protects these cells from cisplatin-induced cytotoxicity. These effects correlated with amelioration of cisplatin-mediated activation of ERK1/2 kinases and decreased cleavage of caspase 3. Similarly to erythropoietin, a selective ERK1/2 inhibitor significantly reduced cisplatin-induced cytotoxicity against neuronal cells. Importantly, using the same experimental setting we did not observe any protection from cisplatin cytotoxicity against four established tumor cell lines. Altogether our studies confirm that erythropoietin might be an effective cytoprotective agent that reduces cisplatin-induced neurotoxicity.

Related Articles

Journal Cover

December 2007
Volume 31 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nowis D, Legat M, Bil J, Kurzaj Z, Issat T, Stoklosa T, Mioduszewska B, Kaczmarek L, Jakóbisiak M, Golab J, Golab J, et al: Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. Int J Oncol 31: 1547-1552, 2007
APA
Nowis, D., Legat, M., Bil, J., Kurzaj, Z., Issat, T., Stoklosa, T. ... Golab, J. (2007). Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. International Journal of Oncology, 31, 1547-1552. https://doi.org/10.3892/ijo.31.6.1547
MLA
Nowis, D., Legat, M., Bil, J., Kurzaj, Z., Issat, T., Stoklosa, T., Mioduszewska, B., Kaczmarek, L., Jakóbisiak, M., Golab, J."Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells". International Journal of Oncology 31.6 (2007): 1547-1552.
Chicago
Nowis, D., Legat, M., Bil, J., Kurzaj, Z., Issat, T., Stoklosa, T., Mioduszewska, B., Kaczmarek, L., Jakóbisiak, M., Golab, J."Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells". International Journal of Oncology 31, no. 6 (2007): 1547-1552. https://doi.org/10.3892/ijo.31.6.1547